|
YWHAQ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.965000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.583800E-02 |
| Normal-vs-Stage2 |
6.858100E-02 |
| Normal-vs-Stage3 |
4.483400E-03 |
| Normal-vs-Stage4 |
1.483930E-02 |
| Stage1-vs-Stage2 |
6.485000E-01 |
| Stage1-vs-Stage3 |
1.864640E-01 |
| Stage1-vs-Stage4 |
3.524200E-01 |
| Stage2-vs-Stage3 |
6.386800E-01 |
| Stage2-vs-Stage4 |
7.925800E-01 |
| Stage3-vs-Stage4 |
8.134400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.484000E-03 |
| Normal-vs-AfricanAmerican |
9.79629999999787E-05 |
| Normal-vs-Asian |
4.796600E-01 |
| Caucasian-vs-AfricanAmerican |
3.091600E-02 |
| Caucasian-vs-Asian |
1.686770E-01 |
| AfricanAmerican-vs-Asian |
2.046100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.779090E-03 |
| Normal-vs-Female |
3.324400E-02 |
| Male-vs-Female |
3.330200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.851800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.017200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.800330E-02 |
| Normal-vs-Age(81-100Yrs) |
2.485900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.061400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.564600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.330200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.914400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.718800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.267400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.211400E-01 |
| Normal-vs-Grade 2 |
1.211790E-01 |
| Normal-vs-Grade 3 |
4.191700E-04 |
| Normal-vs-Grade 4 |
3.120400E-03 |
| Grade 1-vs-Grade 2 |
8.114600E-01 |
| Grade 1-vs-Grade 3 |
2.339600E-01 |
| Grade 1-vs-Grade 4 |
2.185000E-01 |
| Grade 2-vs-Grade 3 |
1.604460E-02 |
| Grade 2-vs-Grade 4 |
4.908100E-02 |
| Grade 3-vs-Grade 4 |
7.709600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.300100E-02 |
| Normal-vs-ccB subtype |
3.263600E-02 |
| ccA subtype-vs-ccB subtype |
4.261800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.466270E-02 |
| Normal-vs-N1 |
7.994000E-01 |
| N0-vs-N1 |
4.897000E-01 |
|
|
